Iovance Biotherapeutics, Inc. (IOVA) quarterly cash flow statement — complete operating, investing & financing history
Iovance Biotherapeutics, Inc. (IOVA) cash flow statement — 18-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -60.84M | -72.07M | -52.56M | -78.7M | -67.45M | -103.69M | -73.3M | -58.97M | -98.43M | -122.28M | -83.97M | -84.08M | -93.95M | -99.81M | -77.67M | -63.65M | -77.64M | -73.8M | -53.85M | -57.69M |
| Operating CF Margin % | -61.26% | -100.9% | -60.58% | -116.67% | -112.5% | -210.23% | -99.46% | -100.72% | -316.43% | -17101.96% | -17421.16% | -17928.15% | -39475.63% | - | - | - | - | - | - | - |
| Operating CF Growth % | 9.79% | 30.49% | 28.28% | -33.45% | 31.48% | 15.2% | 12.71% | 29.86% | -4.77% | -22.51% | -8.11% | -32.1% | -21.02% | -35.25% | -44.24% | -10.32% | -43.75% | -18.29% | 14.11% | -42.4% |
| Net Income | -47.31M | -79.05M | -71.9M | -91.25M | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M |
| Depreciation & Amortization | 6.62M | 7.59M | 17.86M | 11.68M | 11.94M | 11.06M | 11.69M | 11.15M | 10.86M | 9.91M | 9.71M | 9.88M | 7.84M | 5.7M | 5.71M | 5.2M | 5.2M | 4.98M | 4.58M | 3.96M |
| Stock-Based Compensation | 11.73M | 11.27M | 11.82M | 11.9M | 14.94M | 22.91M | 30.98M | 31.01M | 30.47M | 17.18M | 14.4M | 15.82M | 16.74M | 15.66M | 19.51M | 19.78M | 0 | 22.27M | 0 | 19.31M |
| Deferred Taxes | -1.37M | -665K | 184K | -2.4M | 1.99M | -1.84M | 1.56M | -1.52M | -1.46M | -1.41M | -1.76M | -1.24M | -477K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.33M | 1.66M | -3.23M | -88K | 6.15M | -2.04M | -981K | -2.75M | -2.49M | -2.43M | -1.83M | -666K | -58K | -978K | -571K | 133K | 22.97M | 855K | 19.94M | 1.31M |
| Working Capital Changes | -35.83M | -12.88M | -7.29M | -8.53M | 9.19M | -17.63M | -37.98M | -13.32M | -38.71M | -32.55M | 11.89M | 5.89M | -11.47M | -12.83M | 3M | 10.85M | -6.46M | -10.29M | 20.96M | 3.84M |
| Change in Receivables | -20.36M | 690K | -15.69M | -6.82M | 11M | -1.6M | -13.57M | -24.16M | -31.37M | -83K | 0 | 33K | -33K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -177K | -4.93M | -4M | -3.18M | 6.94M | -13.97M | -13.45M | -10.87M | -8.86M | -6.74M | -923K | 354K | -9.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -11.82M | 15.89M | -5.21M | -4.39M | 893K | 2.05M | -6.07M | 14.44M | -10.39M | -5.82M | 11.42M | -9.77M | 146K | 3.02M | 1.56M | 4.26M | 2.17M | -2.1M | 7.72M | -5.69M |
| Cash from Investing | -74.05M | 11.39M | 775K | 17.01M | 13.84M | 15.87M | 23.68M | -48.8M | 40.22M | -111.51M | -72.84M | -79.01M | -156.78M | 153.4M | 461K | 73.72M | 95.76M | 86.52M | 69.34M | 12.75M |
| Capital Expenditures | -5.44M | -6.61M | -9.32M | -10.84M | -7.46M | -6.21M | -4.17M | -2.29M | -442K | -4.17M | -3.53M | -3.58M | -9.52M | -5.66M | -3.02M | -1.39M | -4.58M | -11.44M | -7.57M | -9.69M |
| CapEx % of Revenue | 5.48% | 9.25% | 10.74% | 16.08% | 12.45% | 12.59% | 5.66% | 3.91% | 1.42% | 583.36% | 732.16% | 762.69% | 4000% | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -52.57M | 253K | -3.38M | -209.51M | 0 | -3.48M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.48M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 49.29M | 94.33M | 56.17M | 88.06M | 13.23M | 143.31M | 2.31M | 41.95M | 152.82M | 193.58M | 962K | 202.8M | 1.02M | 258.17M | 190.57M | 225K | -2.07M | 1.42M | 4.15M | 20.77M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 50.45M | 98.51M | 56.62M | 88.52M | 13.06M | 148.94M | 3.19M | 47.52M | 151.87M | 197.91M | 1K | 203.18M | 0 | 260.1M | 189.5M | 225K | 582K | 1.42M | 4.15M | 1K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.17M | -4.18M | -445K | -466K | 165K | -5.63M | -880K | -5.56M | 952K | -4.34M | 961K | -379K | 1.02M | -1.93M | 1.07M | 0 | -2.65M | 0 | 0 | 20.77M |
| Net Change in Cash | -190.5M | -157.09M | 4.96M | 25.69M | -39.64M | 56M | -48.49M | -64.57M | 94.49M | -40.7M | -152.83M | 37.71M | -253.47M | 311.75M | 113.36M | 10.29M | 15.71M | 14.13M | 19.64M | -24.17M |
| Free Cash Flow | -66.28M | -78.68M | -61.88M | -89.55M | -74.91M | -109.91M | -77.46M | -61.26M | -98.87M | -126.45M | -87.5M | -87.66M | -103.47M | -105.48M | -80.69M | -65.04M | -82.21M | -85.24M | -61.42M | -67.38M |
| FCF Margin % | -66.74% | -110.15% | -71.32% | -132.75% | -124.95% | -222.82% | -105.12% | -104.62% | -317.85% | -17685.31% | -18153.32% | -18690.83% | -43475.63% | - | - | - | - | - | - | - |
| FCF Growth % | 11.52% | 28.41% | 20.11% | -46.17% | 24.24% | 13.08% | 11.47% | 30.12% | 4.45% | -19.88% | -8.43% | -34.79% | -25.86% | -23.74% | -31.39% | 3.48% | -29.21% | -16.62% | 28.61% | -15.45% |
| FCF per Share | -0.15 | -0.19 | -0.15 | -0.25 | -0.22 | -0.34 | -0.25 | -0.20 | -0.35 | -0.47 | -0.34 | -0.36 | -0.46 | -0.49 | -0.49 | -0.41 | -0.52 | -0.54 | -0.39 | -0.43 |
| FCF Conversion (FCF/Net Income) | 1.29x | 0.91x | 0.73x | 0.86x | 0.60x | 0.89x | 0.93x | 0.71x | 1.01x | 1.08x | 0.72x | 0.74x | 0.88x | 0.93x | 0.74x | 0.64x | 0.78x | 0.81x | 0.54x | 0.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |